Xiaoying Yang
Impact in
- Biological Psychiatry top 2%
- Biomaterials top 2%
- Nanoparticle-Based Drug Delivery
Papers in
-
- Gut microbiota and health 10
- Ginseng Biological Effects and Applications 6
- Oncology 14
- Pancreatic and Hepatic Oncology Research 4
- Co-authors
- Yongsheng Chen (8 shared papers)Rongcun Yang (3 shared papers)Yanfeng Ma (6 shared papers)Yinsong Wang (7 shared papers)Hong‐Quan Duan (3 shared papers)Xin Huang (1 shared paper)Yi Huang (1 shared paper)Wei Pan (21 shared papers)
- Journals
- Frontiers in Oncology (5 papers)Scientific Reports (4 papers)Frontiers in Immunology (3 papers)Brain Behavior and Immunity (3 papers)Polymer (3 papers)
- Partner nations
- ChinaUnited StatesAustralia
In The Last Decade
Xiaoying Yang
156 papers receiving 4.5k citations
Xiaoying Yang's Hit Papers
Peers
Comparison fields: 5 of 160
- Biological Psychiatry 133
- Biomaterials 442
- Geriatrics and Gerontology 84
- Molecular Medicine 124
- Molecular Biology 1.3k
Countries citing papers authored by Xiaoying Yang
This map shows the geographic impact of Xiaoying Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoying Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoying Yang more than expected).
Fields of papers citing papers by Xiaoying Yang
This network shows the impact of papers produced by Xiaoying Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoying Yang. The network helps show where Xiaoying Yang may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiaoying Yang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 168 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 466 | |
| 2 | Tiragolumab plus atezolizumab versus placebo plus atezolizumab as a first-line treatment for PD-L1-selected non-small-cell lung cancer (CITYSCAPE): primary and follow-up analyses of a randomised, double-blind, phase 2 study Hit paper breakdown → | 2022 | 313 |
| 3 | 2006 | 212 | |
| 4 | 2020 | 203 | |
| 5 | 2021 | 193 | |
| 6 | 2009 | 114 | |
| 7 | 1999 | 108 | |
| 8 | 2017 | 105 | |
| 9 | 2020 | 91 | |
| 10 | 2018 | 83 | |
| 11 | 2014 | 80 | |
| 12 | 2008 | 78 | |
| 13 | 2023 | 72 | |
| 14 | 2022 | 67 | |
| 15 | 2021 | 58 | |
| 16 | 2023 | 53 | |
| 17 | 2022 | 52 | |
| 18 | 2018 | 51 | |
| 19 | 2019 | 50 | |
| 20 | 2020 | 50 |
About Xiaoying Yang
Xiaoying Yang is a scholar working on Molecular Biology, Oncology, Epidemiology, Plant Science and Pulmonary and Respiratory Medicine, having authored 168 papers that have together received 4.5k indexed citations. Recurring topics across this work include Gut microbiota and health (10 papers), Toxoplasma gondii Research Studies (9 papers), Nanoparticle-Based Drug Delivery (7 papers), Meat and Animal Product Quality (6 papers), Ginseng Biological Effects and Applications (6 papers), Tryptophan and brain disorders (5 papers), Adipose Tissue and Metabolism (4 papers) and Pancreatic and Hepatic Oncology Research (4 papers). The work is most often cited by research in Biological Psychiatry (133 citations), Biomaterials (442 citations), Geriatrics and Gerontology (84 citations), Molecular Medicine (124 citations) and Molecular Biology (1.3k citations). Xiaoying Yang has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Yongsheng Chen, Rongcun Yang, Yanfeng Ma, Yinsong Wang, Hong‐Quan Duan, Xin Huang, Yi Huang, Wei Pan, Yinghua Yu and Irene M.C. Lo. Their work appears in journals such as Frontiers in Oncology, Scientific Reports, Frontiers in Immunology, Brain Behavior and Immunity and Polymer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.